G(5')ppp(5')A RNA Cap Structure Analog - 5 µmol

Supplied by New England Biolabs


  • S1406L | G 5 ppp 5 A RNA Cap Structure Analog 5 mol
  • S1406L | G 5 ppp 5 A RNA Cap Structure Analog 5 mol
Average lead time: 5 to 7 Days
Need Assistance?

Jump to Section
Product Description

The 5' terminal m7G cap present on most eukaryotic mRNAs promotes translation in vitro at the initiation level. For most RNAs, elimination of the cap structure causes a loss of stability, especially against exonuclease degradation, and a decrease in the formation of the initiation complex of mRNAs for protein synthesis. Certain prokaryotic mRNAs containing a 5' terminal cap structure are translated as efficiently as or more efficiently than eukaryotic mRNAs in a eukaryotic cell-free protein synthesizing system. Also a cap requirement has been observed for splicing eukaryotic substrate RNAs. A method using E. coli RNA Polymerase primed with m7G(5' )ppp(5' )G or m7G(5' )ppp(5' )A for an efficient in vitro synthesis of capped RNAs has been developed by Contreas. Larger amounts of capped RNAs are produced by transcription systems using SP6 RNA polymerase primed with m7G(5' )ppp(5' )G.
Specifications
Inventory Number:
NEBS1406LEA
Part Number:
S1406L
Supplier:
New England Biolabs
Supplier's Lead Time:
5 to 7 Days
Quantity:
1 per EA
Contract Availability:
Country of Origin:
United States
Additional Information

Contact the GSS Team Today!
GSS-Sales@govsci.com | 800.248.8030 | www.govsci.com

Government Scientific Source
ISO 9001:2015 Certified
Copyright 2026, Government Scientific Source. All Rights Reserved.